You don’t need a fully scoped project to start a conversation. CoreAccess is happy to discuss early questions, pressure-test ideas, or point you toward other resources if there’s a better fit for your needs.
No. Exploratory calls are meant to clarify your market access questions and assess whether CoreAccess can add value. If not, you will still walk away with a clearer view of next steps and, when possible, recommendations on where to go next.
CoreAccess typically partners with life sciences organizations that need focused, pragmatic market access support—ranging from emerging biopharma and biotech to established companies seeking flexible, project-based expertise.
Pricing is driven by the scope and complexity of the work, not by a one-size-fits-all model. Without the overhead of a large firm, CoreAccess can offer competitive—or often lower—fees while maintaining senior-level involvement throughout the engagement.
Yes. CoreAccess supports one-time projects, phased programs, and advisory relationships. The goal is to right-size the work so it fits your team’s bandwidth, timelines, and budget.
If CoreAccess is not the right fit, you will be candidly told so. When possible, you’ll be directed to partners or resources that are better suited to your specific therapeutic area, geography, or type of challenge.
CoreAccess is comfortable collaborating with internal teams, agency partners, and other consultancies. The focus is on clarifying roles, avoiding duplication, and ensuring market access insights are integrated across workstreams.